EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Potential Differences in Psychedelic Actions Based on Biological Sex

Sheida Shadani iD, Kyna Conn iD, Zane B Andrews iD, Claire J Foldi iD

Endocrinology · 01.07.2024 · 165 (8)

DOI: 10.1210/endocr/bqae083 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology, online erschienen am 09.07.2024. Verfasst von Sheida Shadani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Monash University, Clayton, VIC 3800, Australia. Hauptthemen laut MEDLINE: Hallucinogens, Serotonin, Sex Characteristics. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The resurgence of interest in psychedelics as treatments for psychiatric disorders necessitates a better understanding of potential sex differences in response to these substances. Sex as a biological variable (SABV) has been historically neglected in medical research, posing limits to our understanding of treatment efficacy. Human studies have provided insights into the efficacy of psychedelics across various diagnoses and aspects of cognition, yet sex-specific effects remain unclear, making it difficult to draw strong conclusions about sex-dependent differences in response to psychedelic treatments. Compounding this further, animal studies used to understand biological mechanisms of psychedelics predominantly use one sex and present mixed neurobiological and behavioral outcomes. Studies that do include both sexes often do not investigate sex differences further, which may hinder the translation of findings to the clinic. In reviewing sex differences in responses to psychedelics, we will highlight the direct interaction between estrogen (the most extensively studied steroid hormone) and the serotonin system (central to the mechanism of action of psychedelics), and the potential that estrogen-serotonin interactions may influence the efficacy of psychedelics in female participants. Estrogen influences serotonin neurotransmission by affecting its synthesis and release, as well as modulating the sensitivity and responsiveness of serotonin receptor subtypes in the brain. This could potentially influence the efficacy of psychedelics in females by modifying their therapeutic efficacy across menstrual cycles and developmental stages. Investigating this interaction in the context of psychedelic research could aid in the advancement of therapeutic outcomes, especially for conditions with sex-specific prevalence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensSerotoninSex CharacteristicsHumansFemaleAnimalsMaleEstrogens

Stichwörter der Autor:innen

cognitionestrogenlearningpsilocybinpsychedelicsserotoninsex differences

Substanzen

HallucinogensSerotoninEstrogens

Autor:innen und Institutionen

  • Department of Physiology, Monash University, Clayton, VIC 3800, Australia.
  • Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

ORCID-Profile: Sheida Shadani, Kyna Conn, Zane B Andrews, Claire J Foldi

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Shadani, S., Conn, K., Andrews, Z. B., & Foldi, C. J. (2024). Potential Differences in Psychedelic Actions Based on Biological Sex. Endocrinology, 165(8). https://doi.org/10.1210/endocr/bqae083

Vancouver

Shadani S, Conn K, Andrews ZB, Foldi CJ. Potential Differences in Psychedelic Actions Based on Biological Sex. Endocrinology. 2024;165(8). doi:10.1210/endocr/bqae083

BibTeX
@article{Shadani2024,
  author = {Shadani, Sheida and Conn, Kyna and Andrews, Zane B and Foldi, Claire J},
  title = {Potential Differences in Psychedelic Actions Based on Biological Sex},
  journal = {Endocrinology},
  year = {2024},
  volume = {165},
  number = {8},
  doi = {10.1210/endocr/bqae083}
}
Kostenlos starten →